Literature DB >> 1856481

Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion.

C E Rubens1, H V Raff, J C Jackson, E Y Chi, J T Bielitzki, S L Hillier.   

Abstract

Four pregnant Macaca nemestrina dams at 140-145 days of gestation received an intraamniotic inoculation of group B streptococci (GBS). All four premature infants were born by cesarean delivery, were bacteremic at birth, and showed symptoms of GBS sepsis similar to infected human infants with early-onset disease. Three infants did not receive antibiotics and died of GBS sepsis by 10 h of age despite mechanical ventilation and fluids for blood pressure support. Penicillin treatment of the fourth infant prolonged survival and decreased the requirement for supportive therapy. Quantitative cultures and histopathology were done on all four infants. Transmission electron microscopy of lung tissue demonstrated GBS within membrane-bound vacuoles of type I and II alveolar epithelium and interstitial fibroblasts. This model should be useful for studying the early steps in the pathogenesis of early-onset GBS infections. GBS may enter alveolar epithelial cells to transit this barrier and ultimately disseminate via the blood-stream.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856481     DOI: 10.1093/infdis/164.2.320

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Respiratory epithelial cell invasion by group B streptococci.

Authors:  C E Rubens; S Smith; M Hulse; E Y Chi; G van Belle
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 3.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 4.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

5.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Group B Streptococcus induces a caspase-dependent apoptosis in fetal rat lung interstitium.

Authors:  David E Kling; Inna Tsvang; Miriam P Murphy; David S Newburg
Journal:  Microb Pathog       Date:  2013-04-25       Impact factor: 3.738

7.  Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.

Authors:  J L Burns; M Jonas; E Y Chi; D K Clark; A Berger; A Griffith
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

8.  Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells.

Authors:  R L Gibson; C Soderland; W R Henderson; E Y Chi; C E Rubens
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Relevance of peptide uptake systems to the physiology and virulence of Streptococcus agalactiae.

Authors:  Ulrike Samen; Birgit Gottschalk; Bernhard J Eikmanns; Dieter J Reinscheid
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

10.  Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.

Authors:  Hiroshige Mikamo; Atul K Johri; Lawrence C Paoletti; Lawrence C Madoff; Andrew B Onderdonk
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.